HSGN-94 is a potent antibacterial agent that inhibits lipoteichoic acid (LTA) biosynthesis; it exhibits activity against drug-resistant Gram-positive bacteria with MIC values of 0.25–2 μg/mL; it inhibits biofilm formation by MRSA and vancomycin-resistant Enterococci; it also suppresses pro-inflammatory cytokines and demonstrates in vivo efficacy in a MRSA murine wound infection model.